Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blumberg Capital is an early-stage venture capital firm that invests in technology-driven companies across several sectors, including healthtech, fintech, and enterprise software. The firm specializes in leading Seed and Series A rounds, providing capital and strategic guidance to startups developing innovative digital health solutions and AI-powered healthcare platforms. While not a drug developer, Blumberg Capital is a significant player in the healthcare ecosystem through its investments in health information technology and clinical data analytics. The firm is headquartered in San Francisco with additional offices in Tel Aviv, Miami, and New York. Their portfolio includes companies focused on improving clinical workflows, patient engagement, and diagnostic accuracy through advanced software.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blumberg Capital.